- Dissecting genotype-by-environment interactions and genetic diversity in gamma irradiation-derived bread wheat (Triticum aestivum L.) mutants. [Journal Article]Front Plant Sci. 2026; 17:1895559.FP
- Climate change and escalating biotic pressures, particularly stripe (yellow) rust, present major challenges to sustainable wheat production in India and globally. To enhance genetic diversity and introduce novel variations, this study utilized mutation breeding by subjecting seeds of the popular wheat variety DBW88 to gamma irradiation. Following rigorous selection through successive generations,…
- PMC Free PDF
- Insights into Drug Absorption Impairment Mechanisms in Hepatic Impairment using Physiologically-based Pharmacokinetic Modelling: A Case Study with Nilotinib. [Journal Article]AAPS J. 2026 Oct 07; 28(6).AJ
- Nilotinib is reported to have a reduced maximal drug concentration (Cmax) in patients with hepatic impairment (HI). Given this compound is poorly soluble, highly lipophilic and has a positive food effect, reduced absorption in HI may be due to impaired micelle-mediated solubility resulting from reduced intestinal bile salts. PBPK modelling can be used to test this hypothesis as well as being a di…
- Publisher Full Text (DOI)
- Extreme Diagnostic and Therapeutic Heterogeneity Limits Treatment Conclusions in Iliotibial Band Syndrome: A Systematic Review with Level-of-Evidence Stratification. [Review]Orthop Res Rev. 2026; 18:629195.OR
- CONCLUSIONS: Despite a broad therapeutic landscape, most treatment modalities cannot yet be recommended over one another. Structured rehabilitation remains the reasonable first-line approach for newly diagnosed ITBS. For refractory ITBS, emerging Level I evidence supports ultrasound-guided PRP as a promising, though not yet independently replicated, minimally invasive option; corticosteroid injection, instrumental therapies and surgery may be considered in selected cases. The absence of standardized diagnostic criteria and extreme methodological heterogeneity across studies - rather than limitations of this review - preclude more definitive conclusions. Future research must prioritize diagnostic standardization and rigorous head-to-head comparative trials, including independent replication of the PRP findings.
- PMC Free PDF
- Reforming pedagogy in biotechnology pharmaceutics education: a narrative review of emerging teaching strategies. [Review]
- The rapid expansion of the biopharmaceutical industry, driven by monoclonal antibodies, cell and gene therapies, and mRNA vaccines, demands a workforce equipped with interdisciplinary knowledge, practical competence, and critical thinking. Traditional lecture-based instruction in Biotechnology Pharmaceutics usually falls short in cultivating these attributes. This narrative review, drawing on a s…
- PMC Free PDF
- Efficacy and safety of PD-1 inhibitors plus chemotherapy for advanced unresectable gastroesophageal cancer: a systematic review and meta-analysis of phase III randomized controlled trials. [Systematic Review]
- CONCLUSIONS: Findings from this comprehensive study confirm that immunotherapy combined with chemotherapy is more efficacious than traditional chemotherapy in the first-line treatment of patients with advanced unresectable GEC. Sintilimab combined with chemotherapy demonstrated favorable efficacy and safety profiles compared with other PD-1 therapies in terms of OS and PFS benefit without increasing TRAE base on indirect comparisons. The moderate evidence indicated PD-1 combined with chemotherapy may be a viable option for advanced unresectable GEC.
- PMC Free PDF
- Cost-effectiveness of first-line aumolertinib versus osimertinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer in China. [Journal Article]Front Public Health. 2026; 14:1858476.FP
- CONCLUSIONS: Under the current Chinese pricing environment and available indirect comparative evidence, aumolertinib and osimertinib showed broadly similar economic profiles as first-line treatment for advanced EGFR-mutated NSCLC.
- PMC Free PDF
- Androgen receptor inhibitor double therapies in the management of metastatic castration-sensitive prostate cancer: a cost-effectiveness analysis. [Journal Article]J Med Econ. 2026 Dec; 29(1):2423-2436.JM
- CONCLUSIONS: DARO+ADT was cost-effective versus ENZA+ADT and dominant versus APA+ADT, driven by improved tolerability and treatment persistence, supporting its value as a first-line mCSPC option.
- Publisher Full Text (DOI)
- Genetic response on postweaning growth performance in three lines of meat rabbit selected for feed efficiency using alternative criteria. [Journal Article]Animal. 2026 Sep 17; 20(11):101960. [Online ahead of print]A
- Improving feed efficiency is a major goal in rabbit production, as feed costs account for over 60% of total expenses. This study evaluated the genetic responses of three group-housed rabbit lines selected according to alternative criteria for feed efficiency, all of which accounted for social interaction effects: average daily gain under feed restriction (ADGR), cage-level residual feed intake un…
- Publisher Full Text (DOI)
- Higher Loading Dose of Colistin for the Treatment of Ventilator-Associated Pneumonia in Critically Ill Children: A Retrospective Comparative Study at Queen Rania Abdullah Hospital for Children. [Journal Article]
- CONCLUSIONS: A higher loading dose of colistin (9 mg/kg CBA) in children with VAP caused by carbapenem-resistant organisms was associated with improved microbiological eradication, faster clinical response, and shorter duration of mechanical ventilation and PICU stay, while nephrotoxicity did not differ significantly between groups. These findings are hypothesis-generating and require confirmation in larger, prospective, preferably multicenter randomized studies.
- PMC Free PDF
- Endovascular management of brachiocephalic vein stenosis and occlusion in hemodialysis patients: Technical outcomes and 6-month dialysis access patency. [Journal Article]
- CONCLUSIONS: Endovascular management of BCV stenosis and occlusion is safe and effective, with high technical success and favorable short-term clinical outcomes. Balloon venoplasty remains the primary treatment, with selective stent placement providing durable results in cases of recoil or persistent stenosis. Chronic total occlusions remain the principal technical limitation.
- PMC Free PDF
- Efficacy and Safety of Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Non-BRCA Mutation Subgroup of Patients with Metastatic Castration-resistant Prostate Cancer in the PROpel Trial. [Journal Article]Eur Urol Oncol. 2026 Oct 05. [Online ahead of print]EU
- CONCLUSIONS: Olaparib plus abiraterone provided numerically longer rPFS versus placebo plus abiraterone, with no new safety signals, in the non-BRCAm subgroup of patients with mCRPC in PROpel. Our findings support olaparib plus abiraterone as an important new treatment option for consideration in patients with non-BRCAm mCRPC.
- Publisher Full Text (DOI)
- Facilitators and Barriers to Pelvic Floor Muscle Exercise Among Patients with Pelvic Floor Dysfunction: A Meta-Synthesis. [Review]
- CONCLUSIONS: PFMT for women with PFD is influenced by multiple factors. Clinicians should address barriers, strengthen promoting factors, and actively optimize intervention strategies to provide patients with diverse, individualized pelvic floor muscle exercise (PFME) programs.
- Publisher Full Text (DOI)
- A resource consumption analysis of expanded hemodialysis compared to online hemodiafiltration: A provider perspective in Spain. [Journal Article]Nefrologia (Engl Ed). 2026 Oct; 46(8):501535.N
- CONCLUSIONS: HDx with Theranova offers lower resource use and lower costs compared to OL-HDF by reducing the need for specific consumables other than the dialyzer and for water consumption. These findings support the potential benefit of HDx as an efficient dialysis modality that responsibly uses the planet's resources.
- Publisher Full Text (DOI)
- Therapeutics in Axial Spondyloarthritis: A Review of What Works - SPARTAN 2026 Annual Meeting Proceedings. [Review]
- Axial spondyloarthritis (axSpA) encompasses a broad disease spectrum, and the management landscape has expanded considerably over the past two decades. This review synthesizes the current evidence on pharmacological and non-pharmacological interventions in axSpA, addressing both symptom control and radiographic outcomes across drug classes and patient contexts.
- Publisher Full Text (DOI)
- PARP inhibitor-based first-line maintenance therapy for newly diagnosed advanced ovarian cancer across molecular subgroups: an updated systematic review and network meta-analysis. [Systematic Review]
- CONCLUSIONS: This network meta-analysis supports biomarker-directed PARP inhibitor-based first-line maintenance in advanced ovarian cancer, with the greatest PFS benefit in BRCA-mutated and HRD-positive populations. No active regimen demonstrated statistically significant superiority within the connected network. The incremental benefit of adding antiangiogenic therapy to PARP inhibition remains uncertain because connected-network evidence for combination strategies was limited and PAOLA-1 could not be incorporated into the primary network. These findings should not be interpreted as evidence against the clinical value of olaparib plus bevacizumab or combination maintenance strategies in general. Treatment selection should integrate molecular status, prior bevacizumab exposure, safety, treatment availability, and patient preference.
- PMC Free PDF